What changed 10-Q

Item 5. Other Information

2021-05-03 compared with 2020-11-02 · 3 added, 8 removed, 23 unchanged (32% of the section changed)

4 unchanged sentences

Amended and Restated Bylaws.

Offer Letter, dated September 4, 2020, and Indefinite Term Employment Contract, dated October 5, 2020, between Rhythm Pharmaceuticals, Inc.

and Yann Mazabraud.

Separation Agreement, dated September 30, 2020, between Rhythm Pharmaceuticals, Inc.

and Nithya Desikan.

Summary of Non-Employee Director Compensation Policy.

Certification of the Principal Executive Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.

13 unchanged sentences

RHYTHM PHARMACEUTICALS, INC.

November 2, 2020

President and Chief Executive Officer

(Principal Executive Officer)

November 2, 2020

/s/ Hunter C.

Chief Financial Officer, Treasurer and Secretary

(Principal Financial and Accounting Officer)

Chief Financial Officer and Treasurer

(Principal Financial Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.